TCM
JAZZ icon

Traub Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Traub Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+985
New +$216K 0.21% 115
2025
Q3 		– Sell
-1,000
Closed -$106K – 332
2025
Q2 		$106K Buy
+1,000
New +$109K 0.1% 166

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Traub Capital Management's JAZZ Position: Q2 2026 in Review

Traub Capital Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 985 shares worth $237K. The stake represents 0.21% of the portfolio and ranks #115 among its holdings. This is a return to the name: Traub Capital Management previously reported a position in JAZZ as recently as Q2 2025.

Traub Capital Management first reported a position in JAZZ in Q2 2025 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Traub Capital Management held 985 shares of Jazz Pharmaceuticals worth $237K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Traub Capital Management position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.21% of Traub Capital Management's portfolio in Q2 2026, its #115 holding.
  • Traub Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Traub Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.